共 132 条
[1]
Gandhi PN(2009)Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson’s disease J Neurosci Res 87 1283-1295
[2]
Chen SG(2014)Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies J Neurosci 34 418-433
[3]
Wilson-Delfosse AL(2010)LRRK2 and Parkinson disease Arch Neurol 67 542-547
[4]
Skibinski G(2014)Structural and functional in silico analysis of LRRK2 missense substitutions Mol Biol Rep 41 2529-2542
[5]
Nakamura K(2012)Leucine-rich repeat kinase 2 inhibitors: a patent review (2006–2011) Expert Opin Ther Pat 22 1415-1426
[6]
Cookson MR(2012)Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson’s disease Trends Pharmacol Sci 33 365-373
[7]
Finkbeiner S(2012)Mechanisms of LRRK2-mediated neurodegeneration Curr Neurol Neurosci Rep 12 251-260
[8]
Dächsel JC(2015)Structural characterization of LRRK2 inhibitors J Med Chem 58 3751-3756
[9]
Farrer MJ(2010)The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson’s disease Nat Rev Neurosci 11 791-797
[10]
Cardona F(2009)The R1441C mutation alters the folding properties of the ROC domain of LRRK2 Biochim Biophys Acta 1792 1194-1197